About: Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article published 10 July 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2018 (uk) scholarly article published 10 July 2018 (en)
publication date	wds:Q57898894-BD0BC6C9-63D8-4C7D-AD13-477503ACD38E
publication date	2018-07-10 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57898894-94F5B36B-B3E4-4CCE-86B5-CBE25BD41B12
language of work or name	English
cites work	wds:Q57898894-014E1346-702A-4792-816B-96402A9910DD wds:Q57898894-0B3AD3E0-2AC9-4BFA-8A7C-315019DAB4CE wds:Q57898894-0CDC15BF-3D58-4B56-97C6-FB27248317FC wds:Q57898894-0EA59FD8-E5D3-423D-AA55-406D390EDF12 wds:Q57898894-22BF2D3D-2929-40A4-BEAF-21D29329927D wds:Q57898894-292DBA09-26F9-4F0B-920B-CA04EB3CBA34 wds:Q57898894-3774817F-6959-46A0-92FE-513C0E7239EF wds:Q57898894-48C7964E-816A-441E-9CFC-1F0985764D93 wds:Q57898894-4D659758-86CA-400C-BB65-179316CCF609 wds:Q57898894-545F5626-E504-4780-B6C2-FC11CB234699 wds:Q57898894-594C18C6-94F0-4FD2-8D0D-BB820754F983 wds:Q57898894-5A680D9C-79D7-4CF0-9AEE-EB009C545878 wds:Q57898894-679B2A36-EDCF-4D1C-9B1B-528DB0F48354 wds:Q57898894-77E179D4-69F6-41D2-94A0-AEB1FEFA405A wds:Q57898894-7B3929C2-3169-4768-A658-33245EEBE7A7 wds:Q57898894-A5FA7565-6493-4F26-9F6D-35546C89776B wds:Q57898894-AEAE778D-0A22-475D-A48F-67E04E573700 wds:Q57898894-AF19E25F-DA0F-424A-B3ED-4ED297924300 wds:Q57898894-B4A78A9A-A029-4B66-8449-B173CB8D8D08 wds:Q57898894-B9284C21-6B08-4F0D-8FE0-1BB9FA529288 wds:Q57898894-C70EE30D-7A8E-4621-A3EE-F3D3D52C3621 wds:Q57898894-C7AADC3C-1449-40E4-A9EB-B4657AFAD39C wds:Q57898894-D40ED171-65B1-4757-BF86-2C8B828C25CD wds:Q57898894-DAC6BA94-466C-4A75-A119-55B85929706B wds:Q57898894-DC3D1DE5-654B-46A7-A148-9A5A840C9FB5 wds:Q57898894-DD34441D-1D47-4DFA-B0E6-AD34102EC37F wds:Q57898894-DECAB6C6-F2F8-4367-958B-75BEEF7B1949 wds:Q57898894-F3CB1A4C-9516-4830-8E13-0F961215098C
cites work	Genomic Classification and Prognosis in Acute Myeloid Leukemia P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808 Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. Acute myeloid leukemia: 2013 update on risk-stratification and management Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission Acute myeloid leukemia in the real world: why population-based registries are needed Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience Acute myeloid leukemia: 2016 Update on risk-stratification and management Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022. Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222. Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia Hematopoietic stem cell transplantation for patients with AML in first complete remission Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer Center
author name string	wds:Q57898894-1EEF6239-9DDC-41B4-A531-8EB828B3BD2F wds:Q57898894-4832871D-7732-4167-85FA-C3C46DE35847 wds:Q57898894-A55615A3-FFFE-4E87-819C-CBDCD5348E1D wds:Q57898894-ADDEDD75-6E7F-420D-B464-F08864BCB31C wds:Q57898894-B207A9F9-4534-44E4-A95D-6D99720DDBED wds:Q57898894-D49AB40F-31F4-4985-8CC9-666F29D99848
author name string	Richard M Stone Andrew J Carroll Maria R Baer Joseph O Moore Dimitrios Papaioannou Sumithira Vasu
rdfs:label	Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (en) Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (nl)
skos:prefLabel	Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (en) Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (nl)
name	Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (en) Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission (nl)
author	wds:Q57898894-09AC0C76-6D02-4191-87F4-54980DC7D9C5 wds:Q57898894-0F40A3F4-8127-4881-8D3A-91D2D8DF7DB5 wds:Q57898894-42E2A2E8-98A3-4C77-9494-85B284040C76 wds:Q57898894-573B25F4-D916-4C8B-B1F8-40858A9B4BD2 wds:Q57898894-78CFB1D7-D1A5-4028-A19E-422CB776769D wds:Q57898894-8FCFF326-2666-4361-A2A4-8E33FD65B869 wds:Q57898894-A995FB40-85A4-4290-B39F-174E15AB3B62 wds:Q57898894-C64B63FD-729A-4BC8-8BA9-69E464B2517C wds:Q57898894-E492B4EB-2935-4415-B3B4-FB03F827A3E1 wds:Q57898894-EA4BAB58-A242-4D82-AFB3-A8244FA5EA6A wds:Q57898894-F38F89AC-B594-4D26-99CF-F0CCDF83557A wds:Q57898894-FCC6D5F9-EFC4-46B0-B3EE-D0443ED72AA3
author	Clara D. Bloomfield John C. Byrd Bayard L Powell Krzysztof Mrózek Heiko Becker Jonathan E Kolitz

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software